HLA-haploidentical stem cell transplantation using a low dose ATG and steroid
Phase 2
Recruiting
- Conditions
- acute myeloid leukemia, acute lymphoid leukemia/first or second allogeneic stem cell transplantation
- Registration Number
- JPRN-UMIN000028845
- Lead Sponsor
- Hyogo College of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1. A history of adverse events for agents used in the conditioning treatment or GVHD prophylaxis. 2. Active CNS disorders other than leukemia. 3. Active infection. 4. Doctor's decision that patients are inappropriate for this study in some reasons.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method